-+ 0.00%
-+ 0.00%
-+ 0.00%

Capricor Therapeutics Q2 EPS $(0.70) Misses $(0.58) Estimate

Benzinga·08/13/2026 20:06:47
Listen to the news
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.58) by 20.69 percent. This is a 22.81 percent decrease over losses of $(0.57) per share from the same period last year.